Skip to main content

Danaher Corporation High-growth markets revenue

  • DHR · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$233.02+0.37%Close 13 Nov 2026 · Market value $162.9B

High-growth markets revenue at Danaher Corporation came to $2.0B for the quarter to 25 Sep 2026, up 15.0% from a year earlier.

As Danaher Corporation reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 21 Oct 2026.

By quarter

$1.9BDec 2023$1.5BMar 2024$1.7BJun 2024$1.7BSep 2024$1.9BDec 2024$1.5BMar 2025$1.7BJun 2025$1.8BSep 2025$2.0BDec 2025$1.6BMar 2026$2.0BJun 2026$2.0BSep 2026
Danaher Corporation High-growth markets revenue, every reported period
Period endingHigh-growth markets revenueChange on a yearFiled
25 Sep 2026$2.0Bup 15.0%21 Oct 2026
26 Jun 2026$2.0Bup 15.4%21 Jul 2026
27 Mar 2026$1.6Bup 5.7%21 Apr 2026
31 Dec 2025$2.0Bup 5.9%24 Feb 2026
26 Sep 2025$1.8Bup 2.2%21 Oct 2025
27 Jun 2025$1.7Bup 0.1%22 Jul 2025
28 Mar 2025$1.5Bunchanged22 Apr 2025
31 Dec 2024$1.9Bup 3.2%20 Feb 2025
27 Sep 2024$1.7Bdown 1.6%22 Oct 2024
28 Jun 2024$1.7Bdown 7.9%23 Jul 2024
29 Mar 2024$1.5Bdown 11.9%23 Apr 2024
31 Dec 2023$1.9Bdown 21.5%21 Feb 2024
29 Sep 2023$1.8Bdown 24.0%24 Oct 2023
30 Jun 2023$1.8Bdown 21.0%25 Jul 2023
31 Mar 2023$1.7Bdown 18.0%25 Apr 2023
31 Dec 2022$2.4Bdown 5.1%22 Feb 2023
30 Sep 2022$2.3Bdown 0.6%20 Oct 2022
1 Jul 2022$2.3Bup 2.2%21 Jul 2022
1 Apr 2022$2.1Bup 1.6%21 Apr 2022
31 Dec 2021$2.5Bup 19.1%23 Feb 2022
1 Oct 2021$2.3Bup 28.5%21 Oct 2021
2 Jul 2021$2.3Bup 42.2%22 Jul 2021
2 Apr 2021$2.1Bup 81.9%22 Apr 2021
31 Dec 2020$2.1Bup 31.0%25 Feb 2021
2 Oct 2020$1.8Bup 26.4%22 Oct 2020
3 Jul 2020$1.6Bup 11.9%23 Jul 2020
3 Apr 2020$1.2Bdown 9.4%6 May 2020
31 Dec 2019$1.6Bdown 3.6%21 Feb 2020
27 Sep 2019$1.4Bdown 5.6%24 Oct 2019
28 Jun 2019$1.4Bdown 7.2%18 Jul 2019
29 Mar 2019$1.3Bdown 8.1%18 Apr 2019
31 Dec 2018$1.7B—21 Feb 2019
28 Sep 2018$1.5B—18 Oct 2018
29 Jun 2018$1.5B—19 Jul 2018
30 Mar 2018$1.4B—19 Apr 2018

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Danaher Corporation: Recurring revenue · Nonrecurring revenue · Diagnostics revenue · Life Sciences revenue · Biotechnology revenue · North America revenue · Western Europe revenue · financial statements

Every KPI and segment of DHR, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.